Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Chuan Di, Meptin, Mayon
Synonyms :
procaterol
Class :
Antiasthmatic
Dosage Forms & StrengthsÂ
Dry powder (inhaler)Â
10 mcg/doseÂ
Inhaled a dose of 20 mcg up to 4 times daily
Inhaled a dose of 20 mcg up to 4 times daily
Not determinedÂ
Refer to adult dosingÂ
procaterol: it may decrease the antihypertensive activities of benazepril
atropine: it may increase the severity of hypertension with procaterol
balsalazide: it may increase the severity of hypertension with procaterol
benorilate: it may increase the severity of hypertension with procaterol
carprofen: it may increase the risk of hypertension with procaterol
carvedilol: it may decrease the therapeutic efficacy of procaterol
celecoxib: it may increase the risk or severity of hypertension with procaterol
celiprolol: it may decrease the therapeutic efficacy of procaterol
chlorothiazide: it may increase the risk of hypokalemia with procaterol
chlorpromazine: it may decrease the therapeutic efficacy of procaterol
Actions and SpectrumÂ
procaterol’s primary action is to relax and dilate the smooth muscles of the bronchial airways. This relaxation leads to an expansion of the airways, making it easier for individuals to breathe.
Frequency not defined Â
Increased blood pressureÂ
Acute asthma episodes Â
PalpitationsÂ
Exacerbated heart diseaseÂ
ShockÂ
Anaphylactoid reactionsÂ
TinnitusÂ
Nausea Â
Dry mouthÂ
Gastric discomfort Â
Muscle spasticityÂ
Headache Â
TremorsÂ
DizzinessÂ
Numbness of limbsÂ
DrowsinessÂ
InsomniaÂ
Nasal congestionÂ
RashÂ
PruritusÂ
Cold sweatÂ
Black Box WarningÂ
NoneÂ
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
<b>Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
procaterol acts as a selective beta-2 adrenergic receptor agonist. These receptors are predominantly found in the smooth muscles of the bronchial airways. procaterol binds to beta-2 adrenergic receptors, it activates a signaling pathway that leads to smooth muscle relaxation.Â
PharmacodynamicsÂ
Increased levels of cAMP within the smooth muscle cells activate protein kinase A, an enzyme that regulates muscle tone.Â
Activation of PKA leads to the phosphorylation of specific proteins, including myosin, which ultimately results in relaxation of the smooth muscle.Â
PharmacokineticsÂ
Absorption  Â
procaterol is rapidly absorbed through the respiratory mucosa.Â
DistributionÂ
procaterol is distributed to the lungs. Â
MetabolismÂ
procaterol undergoes metabolism primarily in the liver.Â
Elimination and excretionÂ
procaterol is excreted through the kidneys in the form of urine.Â
AdministrationÂ
procaterol is administered via inhalation using a metered-dose inhaler (MDI) and as a nebulized solution. Â
Patient information leafletÂ
Generic Name: procaterolÂ
Why do we use procaterol?Â
procaterol is used for the treatment of respiratory conditions characterized by bronchoconstriction and airway obstruction. Â
procaterol is also used in the management of COPD, which includes conditions like chronic bronchitis and emphysema.Â